Researchers from the Universities of Tübingen and Würzburg have unveiled a surprising interaction between common dietary elements and the efficacy of medications. Their latest findings, published in PLOS Biology, indicate that caffeine has the capacity to diminish the activity of specific antibiotics when combating Escherichia coli bacteria.
The study meticulously examined how 94 diverse substances, ranging from pharmaceuticals to food ingredients, influenced the functioning of bacterial genes and transport proteins. These vital proteins are responsible for regulating the entry and exit of substances within bacterial cells. It was observed that caffeine initiates a cascade of changes through a gene-regulator called Rob, subsequently impairing the ability of transport proteins to absorb the antibiotic ciprofloxacin effectively.
Interestingly, this phenomenon was not observed in Salmonella enterica, underscoring that even closely related microorganisms can exhibit varied responses to identical stimuli. The authors clarify that this effect does not represent classic antibiotic resistance, but rather a “low-level” temporary alteration in the bacterium`s mechanisms, occurring without genetic mutations.
The researchers suggest that these revelations could significantly influence future medical recommendations. Healthcare providers might, in time, need to consider not only prescribed medications but also the dietary habits of patients — including caffeine consumption — during the course of antibiotic therapy.
In a separate context, previous research has also highlighted the potential for moderate caffeine intake during exercise to enhance physical endurance, particularly in warm environments.
